March 26, 2012 — The American Academy of Neurology (AAN) has published an evidence-based guideline on the use of intravenous immunoglobulin (IVIg) in the treatment of neuromuscular disorders.
A sub-group of KD patients fails initial IVIG treatment, develops persistent or recurrent fever and inflammatory signs, and require repeat IVIG or other therapy. Factors contributing to IVIG treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback